Top 10 Strategic Imperatives Driving Innovation in AI-Enhanced Drug Discovery and Development
Frost & Sullivan
AUGUST 29, 2024
This is fueling the growing demand for outsourcing, with contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) driving industry growth. Conversely, small-to-mid, and emerging biopharma players, with 1 or 2 molecules in the pipeline, contribute over 16%.
Let's personalize your content